Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial
M Balasundaram, R Kumari… - Journal of Dermatological …, 2023 - Taylor & Francis
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …
Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial
M Balasundaram, R Kumari, S Ramassamy - 2023 - pubmed.ncbi.nlm.nih.gov
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …
Efficacy of autologous Platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: A randomized open-label trial.
M Balasundaram, R Kumari… - The Journal of …, 2023 - europepmc.org
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …
(AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate …